This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignees: Otsuka Chemical Co., Ltd., Otsuka Pharmaceutical Company, Limited. Active years: 2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 167 
1 out of 846 
Years Active: 2015
Title: Satoru Nakazato: Innovator in Allergy Treatment
Introduction
Satoru Nakazato is a notable inventor based in Japan, recognized for his contributions to the field of allergy treatment. His innovative work focuses on developing agents that can prevent and treat various allergic diseases.
Latest Patents
Satoru Nakazato holds a patent for a low-molecular polysulfated hyaluronic acid derivative and compositions containing the same. This invention serves as an agent for the prevention and treatment of allergic diseases, including pollinosis, allergic rhinitis, allergic conjunctivitis, atopic dermatitis, and asthma. The patent is represented by specific general formulas, where 'n' can range from 0 to 15, and 'R's can independently represent a hydrogen atom or an SO3H group.
Career Highlights
Throughout his career, Satoru Nakazato has worked with prominent companies such as Otsuka Chemical Co., Ltd. and Otsuka Pharmaceutical Company, Limited. His experience in these organizations has contributed significantly to his expertise in the field of allergy treatment.
Collaborations
Satoru Nakazato has collaborated with notable colleagues, including Kazuaki Kakehi and Hiroaki Asai. Their joint efforts have further advanced research and development in allergy-related innovations.
Conclusion
Satoru Nakazato's work in developing treatments for allergic diseases showcases his commitment to improving health outcomes. His innovative contributions continue to influence the field of allergy treatment.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile